-
Electronic (PDF)
-
CD ROM
-
Hard Copy
-
Enterprisewide
Company Analysis - Forest Laboratories, Inc.
RNCOS E-Services Private Limited, April 2011, Pages: 30
Company Analysis assists individual investors, managers and companies in evaluating opportunities, trends, market innovations as well as in selecting appropriate information solutions in order to make effective investment decisions.
The study covers information on the business structure, areas of operation, products and services offered by the company. It comprises SWOT analysis, Key Ratios, and financials that aid investors in gaining an insight into the company's performance.
The report is based on extensive research using data available from credible publications, trade journals, industry associations and the company sources.
Report Highlights
- Provides a comprehensive version of the company's performance
- Offers key financial data, ratio and SWOT analysis
- Tracks major M&A trends and developments
- Business Profile, SWOT analysis and financial information on top competitors
- View on the company by our analysts
- Supplemented with graphs and tabular information wherever necessary
1. Company Overview
1.1 History
1.2 Business Overview
1.3 Organizational Structure
1.4 Major Mergers & Acquisitions
1.5 Ticker Codes at various Stock Exchange Listings
1.6 Management Profile
2. Product & Services
2.1 Product & Services - An Overview
2.2 Revenue & Income Summary by Geographical Distribution
2.3 Revenue & Income Summary by Product
3. Financial Information for the Fiscal Year
3.1 Financial Summary for the Fiscal Year
3.2 Breakup of Revenue & Sales Trends
3.3 Ratio & Market Indicators
3.4 Earning & Income Estimates
3.5 Stock Analysis
4. SWOT Analysis
4.1 Strength
4.2 Weakness
4.3 Opportunity
4.4 Threats
5. Top Competitors (Key Financials & SWOT Analysis)
5.1 Novo Nordisk A/S
5.2 GlaxoSmithKline
5.3 Eli Lilly & Company
6. Analyst View
List of Tables:
Table 1-1: Forest Laboratories Inc. - Major Mergers & Acquisitions (1995 to 2011)
Table 1-2: Forest Laboratories Inc. - Ticker Codes at various Stock Exchanges
Table 1-3: Forest Laboratories Inc. - Key Management People
Table 3-1: Forest Laboratories Inc. - Financial Overview (Million US$), FY 2010
Table 3-2: Forest Laboratories Inc. - Breakup of Revenue & Sales (Million US$), FY 2008 to FY 2010
Table 3-3: Forest Laboratories Inc. - Key Financial Ratios (FY 2008 to FY 2010)
Table 3-4: Forest Laboratories Inc. - Earning & Income Estimates (Million US$), FY 2008 to FY 2010
Table 5-1: Novo Nordisk A/S - Key Financials (Million US$), 2008-2010
Table 5-2: Novo Nordisk A/S - SWOT Analysis
Table 5-3: GlaxoSmithKline - Key Financials (Million US$), 2007-2009
Table 5-4: GlaxoSmithKline - SWOT Analysis
Table 5-5: Eli Lilly & Company - Key Financials (Million US$), 2008-2010
Table 5-6: Eli Lilly & Company - SWOT Analysis
List of Charts
Figure 2-1: Forest Laboratories Inc. - Net Sales by Geographical Distribution (Million US$), FY 2009 & FY 2010
Figure 2-2: Forest Laboratories, Inc. - Net Sales by Product (%), FY 2010
Figure 3-1: Forest Laboratories, Inc. - Stock Chart
- Novo Nordisk A/S
- GlaxoSmithKline
- Eli Lilly & Company
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
